Matt Tremblay, Ph.D.
Chief Executive Officer
Matt Tremblay, Ph.D., is the Chief Executive Officer of Blackbird Laboratories, a nonprofit technology development platform, and Managing Director of Blackbird BioVentures, an early stage biotech investment fund. Blackbird and Blackbird BioVentures aim to catalyze the creation of new medicines and enabling technologies in Baltimore.
Prior to joining Blackbird, Tremblay was Chief Operating Officer of Scripps Research and its drug discovery division, Calibr. He earned his Ph.D. in Chemistry at Columbia University. Following postdoctoral work in the laboratory of Peter Schultz, Ph.D., at Scripps Research, he led a group at the Genomics Institute of the Novartis Research Foundation until helping to launch and run Calibr for 10 years.